Clinical trial
An Exploratory Study: Dendritic Cells for Immunotherapy of Metastatic Endometrial Cancer Patients
NCT04212377 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Exploratory Study: Dendritic Cells for Immunotherapy of Metastatic Endometrial Cancer Patients
- Lead sponsor
- Radboud University Medical Center
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- April 8, 2019
- Completion date
- March 9, 2021
- Enrollment
- 8 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
endometrial cancer